(formerly referred to as hematoidin
) is the yellow breakdown product of normal heme catabolism
. Heme is formed from hemoglobin, a principal component of red blood cells
. Bilirubin is excreted in bile
, and its levels are elevated in certain diseases. It is responsible for the yellow colour of bruises
and the yellow discolouration in jaundice
. Bilirubin reduction in the gut leads to a product called urobilinogen
which is then oxidized to urobilin
which is excreted in the urine.
Bilirubin consists of an open chain of four pyrrole
-like rings (tetrapyrrole
). In heme
, by contrast, these four rings are connected into a larger ring, called a porphyrin
Bilirubin is very similar to the pigment phycobilin used by certain algae to capture light energy, and to the pigment phytochrome used by plants to sense light. All of these contain an open chain of four pyrrolic rings.
Like these other pigments, bilirubin changes its conformation when exposed to light. This is used in the phototherapy of jaundiced newborns: the isomer of bilirubin formed upon light exposure is more soluble than the unilluminated isomer.
Several textbooks and research articles show incorrect chemical structures for the two isoforms of bilirubin.
Bilirubin is created by the activity of biliverdin reductase
. Bilirubin, when oxidized, reverts to become biliverdin once again. This cycle, in addition to the demonstration of the potent antioxidant activity of bilirubin, has led to the hypothesis that bilirubin's main physiologic role is as a cellular antioxidant.
An indication of the bile pigments rapid passage to the large intestines giving them no time to be transformed into stercobilin (Stercobilin is a substance that makes the dark color of stool)[what? This previous sentence appears incomplete and should not be relied on as to any interpretation of what is stated]. Presence of excessive amount of bilirubin in feces signifies that there is no adequate time for bilirubin and biliverdin to be reduced completely to urobilinogen through the action of putrefying bacteria.
(red blood cells) generated in the bone marrow
are destroyed in the spleen
when they get old or damaged. This releases hemoglobin
, which is broken down to heme
, as the globin parts are turned into amino acids
. The heme is then turned into unconjugated bilirubin in the macrophages
of the spleen. This unconjugated bilirubin is not water soluble. It is then bound to albumin
and sent to the liver
In the liver it is conjugated with glucuronic acid, making it soluble in water. Much of it goes into the bile and thus out into the small intestine. Some of the conjugated bilirubin remains in the large intestine and is metabolised by colonic bacteria to urobilinogen, which is further metabolized to stercobilinogen, and finally oxidised to stercobilin. This stercobilin gives feces its brown color. Some of the urobilinogen is reabsorbed and excreted in the urine along with an oxidized form, urobilin.
Normally, a tiny amount of bilirubin is excreted in the urine, accounting for the light yellow colour. If the liver’s function is impaired or when biliary drainage is blocked, some of the conjugated bilirubin leaks out of the hepatocytes and appears in the urine, turning it dark amber. The presence of this conjugated bilirubin in the urine can be clinically analyzed, and is reported as an increase in urine bilirubin. However, in the disorder hemolytic anemia, an increased number of red blood cells are broken down, causing an increase in the amount of unconjugated bilirubin in the blood. As stated above, the unconjugated bilirubin is not water soluble, and thus one will not see an increase in bilirubin in the urine. Because there is no problem with the liver or bile systems, this excess unconjugated bilirubin will go through all of the normal processing mechanisms that occur (e.g., conjugation, excretion in bile, metabolism to urobilinogen, reabsorption) and will show up as an increase in urine urobilinogen. This difference between increased urine bilirubin and increased urine urobilinogen helps to distinguish between various disorders in those systems.
Unconjugated hyperbilirubinaemia in a neonate can lead to accumulation of bilirubin in certain brain regions, a phenomenon known as kernicterus
, with consequent irreversible damage to these areas manifesting as various neurological deficits, seizures
, abnormal reflexes
and eye movements. The neurotoxicity of neonatal hyperbilirubinemia manifests because the blood-brain barrier
has yet to develop fully, and bilirubin can freely pass into the brain interstitium, whereas more developed individuals with increased bilirubin in the blood are protected. Aside from specific chronic medical conditions that may lead to hyperbilirubinaemia
, neonates in general are at increased risk since they lack the intestinal bacteria that facilitate the breakdown and excretion of conjugated bilirubin in the feces (this is largely why the feces of a neonate are paler than those of an adult). Instead the conjugated bilirubin is converted back into the unconjugated form by the enzyme β-glucuronidase
and a large proportion is reabsorbed through the enterohepatic circulation
Reasonable levels of bilirubin can be beneficial to the organism. Evidence is accumulating that suggests bilirubin can protect tissues against oxidative damage caused by free radicals
and other reactive oxygen species
Statistical analysis of people with high normal or slightly elevated bilirubin levels in blood shows that they have a lower risk of developing cardiovascular diseases. In infants it is not very common for the spleen to destroy red blood cells faster than the liver can conjugate the bilirubin. The effect of this would be more bilirubin in the blood plasma.
Bilirubin is in one of two forms:
|| Reaction |
|| Yes (bound to glucuronic acid)
|| Reacts quickly when dyes are added to the blood specimen. Product is Azobilirubin "Direct bilirubin" |
|| Reacts more slowly. Still produces Azobilirubin. Ethanol makes all bilirubin react promptly. Indirect bilirubin = Total bilirubin - Direct bilirubin |
Total bilirubin measures both BU and BC. Total and direct bilirubin levels can be measured from the blood, but indirect bilirubin is calculated from the total and direct bilirubin.
To further elucidate the causes of jaundice or increased bilirubin, it is usually simpler to look at other liver function tests (especially the enzymes ALT, AST, GGT, Alk Phos), blood film examination (hemolysis, etc.) or evidence of infective hepatitis (e.g., Hepatitis A, B, C, delta, E, etc).
Bilirubin is an excretion product, and the body does not control levels. Bilirubin levels reflect the balance between production and excretion. Thus, there is no "normal" level of bilirubin.
Bilirubin is broken down by light, and therefore blood collection tubes (especially serum tubes) should be protected from such exposure.
Different sources provide reference ranges
which are similar but not identical. Some examples for adults are provided below (different reference ranges are often used for newborns):
|| mg/dL |
| total bilirubin
|| 0.2-1.9, 0.3–1.0, 0.1-1.2 |
| direct bilirubin
|| 0-0.3, 0.1–0.3, 0.1-0.4 |
Mild rises in bilirubin may be caused by
- Hemolysis or increased breakdown of red blood cells.
- Gilbert's syndrome - a genetic disorder of bilirubin metabolism which can result in mild jaundice, found in about 5% of the population.
Moderate rise in bilirubin may be caused by
Very high levels of bilirubin may be caused by
Cirrhosis may cause normal, moderately high or high levels of bilirubin, depending on exact features of the cirrhosis
Indirect bilirubin is fat soluble and direct bilirubin is water soluble.
may be noticeable in the sclera
(white) of the eyes at levels of about 30-50 μmol/l, and in the skin at higher levels. Jaundice is classified depending upon whether the bilirubin is free or conjugated to glucuronic acid
- Conjugated jaundice
- Unconjugated jaundice